HYCAMTIN 0.25 mg (Hycamtin 0.25 mg)
Generic Name: topotecan
Pill with imprint HYCAMTIN 0.25 mg is White, Capsule-shape and has been identified as Hycamtin 0.25 mg. It is supplied by GlaxoSmithKline.
Hycamtin is used in the treatment of small cell lung cancer; cervical cancer; cancer; ovarian cancer and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Hycamtin 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HYCAMTIN 0.25 mg
Hycamtin
- Generic Name
- topotecan
- Imprint
- HYCAMTIN 0.25 mg
- Strength
- 0.25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00007-4205 (Discontinued)
- Inactive Ingredients
-
glyceryl monostearate,
titanium dioxide
Note: Inactive ingredients may vary.
More about Hycamtin (topotecan)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: miscellaneous antineoplastics
- Latest FDA Alerts (1)
Patient resources
- Drug Information
- Hycamtin (Advanced Reading)
- Hycamtin Intravenous (Advanced Reading)
- Hycamtin (Topotecan Capsules)
- Hycamtin (Topotecan Injection)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.